Health Care
Oneview Healthcare Plc (ONE)
Oneview Healthcare provides a cloud-based Care Experience Platform (CXP) for hospitals and healthcare systems, designed to improve the patient experience and streamline clinical workflows. The platform integrates with existing hospital IT infrastructure to deliver personalised education, entertainment, communication tools, and meal ordering directly to the patient's bedside device. Operating globally with key markets in the US, Australia, and the Middle East, Oneview aims to empower patients and support care teams through its digital solution.
Market Cap
A$230M
Shares on Issue
N/A
Price Chart
AI Analysis
Oneview Healthcare is currently in a high-growth phase, focusing on expanding its recurring revenue base by signing long-term contracts with major hospital networks. Recent performance is typically measured by growth in Annual Recurring Revenue (ARR) and new contract wins, rather than profitability, as the company is reinvesting heavily in sales and product development. As a small-cap technology firm, its financial health is closely monitored through its quarterly Appendix 4C cash flow statements, which detail customer receipts, operational spending, and the company's remaining cash runway.
The company's growth outlook is intrinsically tied to the ongoing digitisation of the healthcare sector and the increasing focus on patient satisfaction metrics, which can impact hospital funding in markets like the United States. Key upcoming catalysts for Oneview include the announcement of new, large-scale hospital contracts, expansion into new geographical regions, and reaching cash flow breakeven, which would be a significant de-risking event. Its strategic direction is centered on a 'land and expand' model, securing initial deployments within large healthcare systems and then expanding its footprint across additional hospitals and facilities within that network.
Bull Case
- • Large and growing Total Addressable Market (TAM) as hospitals worldwide invest in digital infrastructure to improve patient outcomes and operational efficiency.
- • Proven ability to win multi-year, high-value contracts with major US hospital networks, creating a sticky and predictable recurring revenue stream.
- • Scalable cloud-based SaaS model offers potential for high gross margins and operating leverage as the customer base grows.
Bear Case
- • The company remains unprofitable and cash-flow negative, requiring potential future capital raises which could dilute existing shareholders.
- • Long and complex sales cycles for enterprise-level hospital contracts can lead to lumpy revenue and unpredictable quarterly results.
- • Significant competition from larger, more established healthcare technology players and smaller niche providers.
Recent Announcements
Change in substantial holding
Notification of Results/Reporting Date
Quarterly Activities/Appendix 4C Cash Flow Report
🚨 Price SensitiveThe ASX announcement for Ticker: ONE indicates that the Commitments Test Entity has released its quarterly cash flow report, detailing significant financial activities and positional changes within the entity. Investors are advised to review this document carefully as it provides critical insights into
FAQs
What does ONE do?
Oneview Healthcare provides a cloud-based software platform for hospitals, known as the Care Experience Platform (CXP). It integrates with a hospital's systems to deliver services like entertainment, meal ordering, video calls, and patient education directly to a screen at the patient's bedside, aiming to improve patient satisfaction and operational efficiency.
Is ONE a good investment?
As a small-cap growth company, Oneview Healthcare is a speculative investment. The potential upside is linked to its ability to secure more large-scale, long-term contracts with major hospital networks, especially in the US. However, risks include its current unprofitability, reliance on capital raising, and intense competition, making its path to consistent profitability uncertain.
What drives ONE's share price?
ONE's share price is primarily driven by news of major contract wins, which directly impact future revenue and validate its technology. Other key drivers include its quarterly cash flow and revenue growth reports (Appendix 4C), progress towards achieving cash flow breakeven, and broader market sentiment towards growth-focused technology stocks.
Key Metrics
Related Stocks
Health Care
CSLCSL Ltd
A$181.24
-27.3% 1Y
CSL is a global biotechnology leader focused on plasma-derived therapies, vaccines, and specialty biologics.
Health Care
PNVPolynovo Ltd
A$0.99
-13.1% 1Y
Polynovo manufactures innovative wound care products used in burns, trauma, and reconstructive surgery.
Health Care
1ADAdalta Limited
A$0.01
-25.6% 1Y
Adalta Limited is a clinical-stage biotechnology company developing its proprietary i-body technology platform for treating a range of diseases. Based in Australia, its lead product candidate, AD-214, is being developed to treat Idiopathic Pulmonary Fibrosis (IPF) and other human fibrotic diseases.